Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients
March 11th, 2021
This paper presents a protocol specifically for dual motor task gait analysis in stroke patients with motor control deficits.
The design of this experimental tasks facilitated a in-depth discussion of motor control function of stroke patients which provides new ideas for clinical diagnosis and evaluation of the gait function of stroke patients. Through dual-motor working tasks and the calculation of dual-task gait cost values, this research protocol aims to provide a basis for the clinical diagnosis of gait function and the in-depth study of motor control in stroke patients. Demonstrating the procedure will be Doctor Shijuan Lang and graduate student Biyi Zhao and Yongchun Jiang from my laboratory.
To begin, recruit stroke patients and obtain written informed consent from all patients before beginning the study. Record the patient's demographic characteristics including name, gender, date of birth, level of education, chief complaint, current medical history, past history, medical treatment, and current medications. Then ask the patient to complete the mini mental state examination in Montreal Cognitive Assessment.
Next, conduct a 10 meter walk test by asking the patient to perform three consecutive trials at a self-selected pace for safety, comfort, and higher speed, respectively. Record the time taken to walk to the middle six meters in each trial. Next, conduct the timed Up and Go"test by asking the patient to perform three consecutive trials at a self-selected pace for safety and comfort.
Before performing the 3D Gait Analysis, inform the patient about the precautions and the purpose of the experiment. Then, record the values of various anthropometric indicators including height, weight, bilateral width of the ankle joints, bilateral knee diameter, pelvic width, bilateral pelvic depth, and bilateral leg length. Next place, twenty-two markers on key points of the patient with three markers on the trunk, three markers on the pelvis, six markers on the thigh six markers on the calf, and four markers on the foot.
Instruct the patient to maintain an upright position on the force plate for at least three to five seconds to gather the baseline data. Then, ask the patient to walk on the walking pass for five trials at a self-selected comfortable speed, which is marked as Task 0"Consider the single walking task as the baseline task. Next, ask the patient to walk while holding a bottle of water on the walking pass for five trials at a self-selected, comfortable speed.
and mark this as Task 1"Finally, ask the patient to walk across the line in the middle of the walking pass for five trials at a self-selected comfortable speed and mark this as Task 2"The demographic characteristics of 18 patients recruited in this study with hemiplegia after stroke are shown here for the original data of Simple Motor dual-task, called Task 1"and Complex Motor dual-Task, called Task 2"there was no statistical difference in the spatiotemporal parameters. However, in the joint angle parameters, the bilateral trunk rotation and the bilateral pelvic rotation in the transversal plane were significantly larger in Task 2 than in Task 1. For the DTC values of Gait dual tasks, the bilateral trunk obliquity in the frontal plane and the bilateral pelvic rotation in the transversal plane were higher in Task 2 than in Task 1.
At the same time, the right cadence in the right GPS were significantly increased in Task 2, relative to that in Task 1. In this study, in addition to the single walking task as the baseline, we mainly focus on comparing two dual tasks of motor performance and walking, including the task of water holding and the task of coursing obstacles. This study aimed explore the effect of dual modal task on the gait of stroke patients and employ DTC values of dual modal parameters to accrue the heterogeneity among stroke patients.
This results suggest that DTC values have an advantage in assessing dual task gait in stroke patients.
View the full transcript and gain access to thousands of scientific videos
Overview
This study investigates motor control and gait function in stroke patients using multitask gait analysis. Eighteen stroke patients underwent cognitive and walking ability assessments, followed by three-dimensional gait analysis under single and dual-task conditions. The protocol emphasizes the use of dual-task gait cost (DTC) values to evaluate heterogeneity in motor performance and provides insights for clinical diagnosis and rehabilitation strategies.
Key Study Components
Area of Science
- Neurorehabilitation
- Gait analysis
- Stroke recovery
Background
- Stroke often leads to motor control deficits and impaired gait function.
- Dual-task paradigms can reveal subtle deficits not apparent during single-task walking.
- Gait analysis is a valuable tool for assessing functional mobility in stroke patients.
- Quantifying dual-task costs may improve clinical evaluation and individualized rehabilitation.
Purpose of Study
- To evaluate the effects of dual-task walking on gait parameters in stroke patients.
- To compare simple and complex motor dual-tasks with single-task walking.
- To assess the utility of DTC values in identifying gait heterogeneity among stroke patients.
Methods Used
- Recruitment of 18 stroke patients with hemiplegia and informed consent.
- Collection of demographic and clinical data, including cognitive assessments (MMSE, MoCA).
- Standardized walking tests: 10-meter walk test and Timed Up and Go test.
- 3D gait analysis with 22 body markers during three tasks: single walking (Task 0), water-holding dual-task (Task 1), and obstacle-crossing dual-task (Task 2).
- Calculation of dual-task gait cost (DTC) values for various kinematic parameters.
Main Results
- No significant differences in spatiotemporal parameters between dual-tasks.
- Significant increases in bilateral trunk and pelvic rotation angles during the complex dual-task (Task 2) compared to the simple dual-task (Task 1).
- Higher DTC values for trunk obliquity and pelvic rotation in Task 2 versus Task 1.
- Right cadence and right gait profile score (GPS) were significantly increased in Task 2.
- DTC values effectively captured heterogeneity in dual-task gait performance among stroke patients.
Conclusions
- Dual-task gait analysis, especially using DTC values, provides valuable insights into motor control deficits in stroke patients.
- Complex dual-tasks elicit greater changes in proximal joint kinematics than simple dual-tasks or single walking.
- This protocol supports improved clinical diagnosis and targeted rehabilitation for gait dysfunction post-stroke.
Frequently Asked Questions
Executive Industry Relevance
Quantitative dual-task gait analysis in post-stroke patients addresses a critical need for objective, reproducible assessment of motor control deficits in neurorehabilitation research. The use of dual-task gait cost (DTC) values enables precise differentiation of patient heterogeneity, supporting translational continuity from discovery to clinical evaluation. This protocol strengthens predictive confidence in functional outcome measures, informing risk-adjusted advancement of neurotherapeutic candidates.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic interrogation of motor control pathways affected by stroke.
- Supports functional target validation through quantifiable gait metrics under multitask conditions.
- Facilitates biological de-risking by revealing subtle deficits not captured in single-task assessments.
- Improves predictive confidence for candidate interventions targeting motor recovery.
Screening & Assay Development
- Establishes validated, reproducible gait analysis protocols for preclinical and clinical studies.
- Provides standardized quantitative outputs (e.g., joint angles, DTC values) for cross-study comparison.
- Enables assay scalability and platform reuse in neurorehabilitation research pipelines.
- Supports reliable evaluation of therapeutic impact on complex motor function.
Translational & Preclinical Research
- Aligns gait analysis outputs with disease-relevant functional endpoints for stroke models.
- Ensures continuity from early discovery through preclinical and clinical validation phases.
- Enables risk-adjusted advancement decisions based on objective functional biomarkers.
- Provides mechanistic de-risking for interventions targeting motor and cognitive integration.
Pipeline & Workflow Integration
This protocol integrates into the neurorehabilitation discovery continuum, bridging early mechanistic studies and translational research through standardized, quantitative gait analysis.
- Discovery Biology: Supports hypothesis testing on motor-cognitive integration and pathway clarification in stroke recovery.
- Screening: Delivers reproducible, quantitative gait metrics for candidate evaluation and cross-cohort comparison.
- Analytics: Provides DTC values and joint kinematic readouts to enable robust statistical analysis of intervention effects.
- Translational Research: Aligns functional gait endpoints with clinical biomarker strategies for preclinical-to-clinical continuity.
- Enterprise Reuse: Offers a reusable, standardized protocol for diverse neurotherapeutic R&D programs.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence and target validation for motor recovery interventions.
- Operational Value: Delivers standardized, scalable, and reproducible gait analysis workflows.
- Strategic Value: Informs go/no-go decisions and reduces late-stage biological risk in neurorehabilitation portfolios.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of neurotherapeutic candidates.
Implementation Considerations
- Requires expertise in gait analysis, neurorehabilitation, and statistical evaluation of kinematic data.
- Needs access to 3D motion capture systems and validated marker placement protocols.
- Demands cross-team standardization for data collection and analysis procedures.
- Adaptation may be needed for different patient populations or model systems.
- Practical limitations include patient safety, cognitive capacity, and protocol adherence.
